US4144250A
(en)
*
|
1973-05-14 |
1979-03-13 |
Stauffer Chemical Company |
Herbicidal active carboxanilide derivatives
|
JPS5830302B2
(ja)
*
|
1974-04-16 |
1983-06-28 |
キツセイヤクヒンコウギヨウ カブシキガイシヤ |
シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
|
GB1484413A
(en)
*
|
1974-04-18 |
1977-09-01 |
Kissei Pharmaceutical |
Aromatic amidocarboxylic acid derivatives
|
DE2629752A1
(de)
*
|
1976-07-02 |
1978-01-05 |
Boehringer Mannheim Gmbh |
Neue carbonsaeurederivate und verfahren zu ihrer herstellung
|
JPS56135454A
(en)
*
|
1980-03-26 |
1981-10-22 |
Kissei Pharmaceut Co Ltd |
Preparation of aromatic carboxylic acid amide derivative
|
US4337270A
(en)
*
|
1980-05-21 |
1982-06-29 |
Hisamitsu Pharmaceutical Co., Inc. |
Novel anthranilic acid derivatives
|
JPS5838244A
(ja)
*
|
1981-09-01 |
1983-03-05 |
Kissei Pharmaceut Co Ltd |
核置換シンナモイルアントラニル酸塩およびその製造方法
|
US4536346A
(en)
*
|
1983-05-06 |
1985-08-20 |
American Cyanamid Company |
Aralkanamidophenyl compounds
|
JPS6097946A
(ja)
*
|
1983-11-01 |
1985-05-31 |
Ono Pharmaceut Co Ltd |
カルボキサミド誘導体
|
JPS60116657A
(ja)
*
|
1983-11-30 |
1985-06-24 |
Ono Pharmaceut Co Ltd |
アニリン誘導体
|
JPS60142936A
(ja)
*
|
1983-12-28 |
1985-07-29 |
Ono Pharmaceut Co Ltd |
置換フエニル誘導体
|
JPS60146857A
(ja)
*
|
1983-12-30 |
1985-08-02 |
Kissei Pharmaceut Co Ltd |
α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
|
JPS60146856A
(ja)
*
|
1983-12-30 |
1985-08-02 |
Kissei Pharmaceut Co Ltd |
α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
|
IT1196348B
(it)
*
|
1984-11-29 |
1988-11-16 |
Italfarmaco Spa |
Composti ad attivita'antiinfiammatoria
|
JPH078851B2
(ja)
*
|
1985-07-29 |
1995-02-01 |
鐘淵化学工業株式会社 |
3−フエニルチオメチルスチレン誘導体
|
JPH0733357B2
(ja)
*
|
1986-09-30 |
1995-04-12 |
日本レダリ−株式会社 |
ケイ皮酸誘導体
|
JPH0692353B2
(ja)
*
|
1987-05-26 |
1994-11-16 |
マルコ製薬株式会社 |
新規なアミノ安息香酸アミド誘導体およびその製造法
|
JP2632732B2
(ja)
*
|
1989-11-06 |
1997-07-23 |
株式会社興人 |
N―(3’,4’―ジメトキシシンナモイル)アントラニル酸の製造方法
|
US5811447A
(en)
*
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
JP2617407B2
(ja)
*
|
1992-09-14 |
1997-06-04 |
キッセイ薬品工業株式会社 |
血管内膜細胞過剰増殖疾患の予防および治療剤
|
US6251920B1
(en)
|
1993-05-13 |
2001-06-26 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US5770609A
(en)
*
|
1993-01-28 |
1998-06-23 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6395494B1
(en)
*
|
1993-05-13 |
2002-05-28 |
Neorx Corporation |
Method to determine TGF-β
|
US6663881B2
(en)
|
1993-01-28 |
2003-12-16 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5595722A
(en)
*
|
1993-01-28 |
1997-01-21 |
Neorx Corporation |
Method for identifying an agent which increases TGF-beta levels
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
WO1996040098A2
(fr)
*
|
1995-06-07 |
1996-12-19 |
Neorx Corporation |
Prevention et traitement de pathologies cardio-vasculaires au moyen d'analogues de tamoxifene
|
DE69435137D1
(de)
*
|
1993-05-13 |
2008-10-16 |
Poniard Pharmaceuticals Inc |
Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
|
US20030083733A1
(en)
*
|
1997-10-10 |
2003-05-01 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US20020091433A1
(en)
*
|
1995-04-19 |
2002-07-11 |
Ni Ding |
Drug release coated stent
|
US6099562A
(en)
*
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
US5837313A
(en)
*
|
1995-04-19 |
1998-11-17 |
Schneider (Usa) Inc |
Drug release stent coating process
|
AU1618697A
(en)
*
|
1996-02-06 |
1997-08-28 |
Japan Tobacco Inc. |
Novel compounds and pharmaceutical use thereof
|
US6019104A
(en)
*
|
1996-12-30 |
2000-02-01 |
Kissei Pharmaceutical Co., Ltd. |
Method for the treatment or prevention of restenosis associated with coronary intervention
|
DE19935219A1
(de)
|
1999-07-27 |
2001-02-01 |
Boehringer Ingelheim Pharma |
Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
|
DE10065043A1
(de)
*
|
2000-12-23 |
2002-07-04 |
Boehringer Ingelheim Pharma |
Carbonsäureamide, diese Verbindungen enthaltene Arzneimittel, deren Verwendung und Herstellung
|
DE10065042A1
(de)
|
2000-12-23 |
2002-06-27 |
Boehringer Ingelheim Pharma |
Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
|
US6613083B2
(en)
*
|
2001-05-02 |
2003-09-02 |
Eckhard Alt |
Stent device and method
|
EP1318141A1
(fr)
*
|
2001-12-04 |
2003-06-11 |
Dsm Nv |
Traitement d'une phase aqueuse contenant des phosphates, du cyclohexanone et l'oxime correspondant
|
WO2003048110A1
(fr)
*
|
2001-12-04 |
2003-06-12 |
Dsm Ip Assets B.V. |
Procede de traitement d'un milieu aqueux contenant de l'oxime de la cyclohexanone et de la cyclohexanone
|
MXPA04005427A
(es)
*
|
2001-12-10 |
2005-04-19 |
Amgen Inc |
Ligandos de receptor vainilloide y su uso en tratamientos.
|
ES2444550T3
(es)
*
|
2002-08-29 |
2014-02-25 |
Temple University - Of The Commonwealth System Of Higher Education |
Arilpropenamidas y heteroarilpropenamidas, derivados de las mismas y usos terapéuticos de las mismas
|
DE10254872A1
(de)
|
2002-11-25 |
2004-06-03 |
Symrise Gmbh & Co. Kg |
Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
|
WO2005110392A1
(fr)
*
|
2004-05-14 |
2005-11-24 |
The University Of Melbourne |
Procedes de modulation de l'activite de flt3
|
KR20070098916A
(ko)
|
2005-01-14 |
2007-10-05 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
T 세포 기능화를 조절하는 방법
|
ITMI20050261A1
(it)
*
|
2005-02-21 |
2006-08-22 |
Carlo Ghisalberti |
Analoghi strutturali di avenatramidi loro uso in composizioni utili nel trattamento di disordini dermatologici
|
EP1886662B1
(fr)
*
|
2006-06-14 |
2014-04-09 |
Symrise AG |
Compositions actives anti-microbiennes destinées au traitement de la mauvaise haleine
|
ES2462925T3
(es)
*
|
2006-06-14 |
2014-05-26 |
Symrise Ag |
Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral
|
US8765812B2
(en)
*
|
2006-07-05 |
2014-07-01 |
Fibrotech Therapeutics Pty Ltd |
Therapeutic compounds
|
WO2008131481A1
(fr)
*
|
2007-04-26 |
2008-11-06 |
Fibrotech Therapeutics Pty Ltd |
Traitement de maladies mésangioprolifératives
|
NZ584613A
(en)
*
|
2007-12-21 |
2011-07-29 |
Fibrotech Therapeutics Pty Ltd |
Halogenated cinnamoylbenzamide derivatives for anti-fibrotic drugs
|
WO2010071865A1
(fr)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Compositions pharmaceutiques et procédés de traitement de l'hyperuricémie et des troubles associés
|
US20100160351A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
WO2010147184A1
(fr)
|
2009-06-17 |
2010-12-23 |
国立大学法人熊本大学 |
Agent prophylactique et/ou thérapeutique pour dysménorrhée
|
EP2947073B1
(fr)
|
2009-10-22 |
2019-04-03 |
Fibrotech Therapeutics Pty Ltd |
Analogues cycliques fusionnés d'agents antifibrotiques
|
DE102009046115A1
(de)
*
|
2009-10-28 |
2011-09-08 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 3-Phenylpropansäuren und ihre Verwendung
|
CN104130156A
(zh)
*
|
2011-01-25 |
2014-11-05 |
三井化学Agro株式会社 |
芳香族酰胺羧酸衍生物的制造方法
|
US10188754B2
(en)
|
2013-05-16 |
2019-01-29 |
The Johns Hopkins University |
Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)
|
CN104693063A
(zh)
*
|
2015-03-18 |
2015-06-10 |
中国药科大学制药有限公司 |
一种曲尼司特的合成方法
|
CN110546133A
(zh)
|
2017-02-03 |
2019-12-06 |
塞尔塔治疗有限公司 |
抗纤维化化合物
|
CN110357789B
(zh)
*
|
2018-04-11 |
2022-09-30 |
华东理工大学 |
作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
|